Search results

Order by most recent / most popular / relevance

Results: 1-10 of 333

Government one-two punches Novartis and exposes dangers of speaker programs

Fish & Richardson PC
-
USA
-
May 9 2013

Late last month, the Government stung Novartis with separate False Claims Act (FCA) suits only days apart. On April 23rd, the Government charged that

CMS announces "winners" of Medicare DMEPOS competitive bidding round 2National Mail order competition

Reed Smith LLP
-
USA
-
April 16 2013

On April 9, 2013, CMS announced the names of 799 suppliers that have been awarded 3-year contracts under Round 2 of the Medicare durable medical

The Tuomey saga continues jury rules that Tuomey violated the Stark Law and False Claims Act

Bricker & Eckler LLP
-
USA
-
May 10 2013

After a four-week trial watched closely by many in the health care industry, on May 8, 2013, a jury concluded that Tuomey Healthcare System in Sumter

Super-sized Stark Law liability: Tuomey subject to False Claims Act liability after jury finds physician employment agreements violated Stark Law

Reinhart Boerner Van Deuren SC
-
USA
-
May 13 2013

After a four-week trial, a federal jury concluded on Wednesday that Tuomey Healthcare System violated both the Stark Law and the False Claims Act by

Sixth Circuit applies strict precondition of payment requirement to reverse $11.1 million FCA judgment

Ropes & Gray LLP
-
USA
-
May 13 2013

The U.S. Court of Appeals for the Sixth Circuit, in United States ex rel. Hobbs v. MedQuest Associates, Inc., 711 F.3d 707 (6th Cir. April 1, 2013

Law enforcement in the health care industry: what do new cases against Novartis tell us?

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
May 9 2013

In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

Alston & Bird LLP
-
USA
-
May 14 2013

Yesterday, the Department of Justice (DOJ) announced that it had entered into a $500 million civil and criminal settlement with Ranbaxy USA, Inc

$39 million jury verdict in False Claims Act suit against Tuomey Healthcare

Haynes and Boone LLP
-
USA
-
May 15 2013

Last week, a federal jury in South Carolina found that Tuomey Healthcare System, Inc. violated the Stark Law and the False Claims Act by submitting

Standing on the tracks - six ways the Affordable Care Act may increase federal contractors' costs

Arnold & Porter LLP
-
USA
-
May 1 2013

Federal contactors face significant cost increases from impending health insurance reform. The Patient Protection and Affordable Care Act (PPACA or

Turning up the heat on hospice care providers

Roetzel & Andress
-
USA
-
May 9 2013

The Department of Justice (DOJ) very recently charged the nation's largest for-profit hospice chain, Vitas Innovative Hospice Care (Vitas), which is

next >

Search results

Government one-two punches Novartis and exposes dangers of speaker programs

CMS announces "winners" of Medicare DMEPOS competitive bidding round 2National Mail order competition

The Tuomey saga continues jury rules that Tuomey violated the Stark Law and False Claims Act

Super-sized Stark Law liability: Tuomey subject to False Claims Act liability after jury finds physician employment agreements violated Stark Law

Sixth Circuit applies strict precondition of payment requirement to reverse $11.1 million FCA judgment

Law enforcement in the health care industry: what do new cases against Novartis tell us?

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

$39 million jury verdict in False Claims Act suit against Tuomey Healthcare

Standing on the tracks - six ways the Affordable Care Act may increase federal contractors' costs

Turning up the heat on hospice care providers

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea